Why we prefer this gas distributor over its peer.
Financial stocks are dicey bets to make when stock markets are expensive and there’s uncertainty over the economic outlook. But here’ an NBFC that is a good portfolio addition today, for investors seeking a defensive stock that can weather any upcoming volatility while delivering long-term wealth.
The year 2020 will go down as a historical one for the stock markets for more reasons than one. If COVID-19-triggered crash in March 2020 was dramatic, the subsequent rise was even more remarkable. If someone had predicted at end of March 2020 that the frontline stock indices would close at lifetime highs by December 2020, I am sure there would not have been too many takers for it.
A dividend cheque hitting our bank accounts is the nicest thing to happen. But lately this has led to some investors thinking that dividend yield
As the Nifty scales new highs, there are specific sectors that are outperforming the index. In a rally such as the present one, if you have a positive outlook on the broad markets, it makes sense to focus on these sectors than look for contrary picks.
The Mrs Bectors IPO, open now and closing on December 17th, has a price band of Rs 286-288, and seeks to raise up to Rs 540.54 crore. With broad-based revenues and strong regional brands, should you go for this IPO?
Burger King, ‘Home of the Whopper’, needs little introduction. , Burger King India holds the exclusive pan-India right to open and operate outlets under the
A 7% decline in revenue but a 17% jump in profits is not an earnings scenario that you see often. We are talking of the September quarter numbers over a year ago for a universe of 1,122 companies. But then, abnormal times throw up abnormal results. How did India Inc achieve these profitability numbers and are they here to stay?
There are more than sixty Public Sector Undertakings (PSUs), seventeen Public Sector Banks (PSBs) and around a dozen State owned undertakings, that are listed on the exchanges. A couple of days ago, some mutual fund managers raised a desperate shout to the government about the ‘non-performance’ of the shares in these undertakings.
While MNC stocks have traditionally enjoyed premium valuations, the last 3 years have seen this space underperform. How do you discover the better ones among them? Use our screener!
When the big boys of Indian stock market – the Nifty 50 pack – see an aggregate 57% drop in their profits for the 6 months ending June 2020 (over a year ago), you wonder whether the others could have fared any better. Were there any high growth companies that bucked the trend?
The Initial Public Offer (IPO) of UTI AMC is hitting the markets today and will close on October 1. This offer of 3.89 crore shares to the public is made up entirely of sale of shares by UTI’s key shareholders – SBI, LIC and Bank of Baroda. In addition, T Rowe Price International Ltd, a long-standing global investor in UTI and PNB a sponsor, are also selling a small part of their holdings. UTI AMC will not receive any capital infusion from these divestments.
The purpose of these disclosures is to provide essential information about the Research Services in a manner to assist and enable the prospective client/client in making an informed decision for engaging in Research services before onboarding. History, Present business and Background: PrimeInvestor Financial Research Private Limited is registered with SEBI as Research Analyst with registration no. INH200008653. The Research Analyst got its registration on August 19, 2021 and is engaged in offering research and recommendation services. Terms and conditions of Research Services: The Research Services will be limited to providing independent research recommendation and shall not be involved in any advisory or portfolio allocation services. The Research Analyst never guarantees the returns on the recommendation provided. Investor shall take note that Investment/trading in stocks/Index or other securities is always subject to market risk. Past performance is never a guarantee of same future results. The Research Analyst shall not be responsible for any loss to the Investors. Disciplinary history: There are no pending material litigations or legal proceedings against the Research Analyst. As on date, no penalties / directions have been issued by SEBI under the SEBI Act or Regulations made there under against the Research Analyst relating to Research Analyst services. Details of its associates: No associates. Disclosures with respect to Research and Recommendations Services: The Research Analyst or its directors or any of its officer/employee does not trade in securities which are subject matter of recommendation. There are no actual or potential conflicts of interest arising from any connection to or association with any issuer of products/ securities, including any material information or facts that might compromise its objectivity or independence in the carrying on of Research Analyst services. Such conflict of interest shall be disclosed to the client as and when they arise. Research Analyst or its directors or its employee or its associates have not received any compensation from the company which is subject matter of recommendation. Research Analyst or its directors or its employee or its associates have not managed or co-managed the public offering of any company. Research Analyst or its directors or its employee or its associates have not received any compensation for investment banking or merchant banking of brokerage services from the subject company. Research Analyst or its directors or its employee or its associates have not received any compensation for products or services other than above from the subject company. Research Analyst or its directors or its employee or its associates have not received any compensation or other benefits from the Subject Company or 3rd party in connection with the research report/ recommendation. The subject company was not a client of Research Analyst or its directors or its employee or its associates during twelve months preceding the date of recommendation services provided. Research Analysts or its directors or its employee or its associates has not served as an officer, director or employee of the subject company. Research Analysts has not been engaged in market making activity of the subject company.
Full disclosures and disclaimers
Compliance Officer Details: Name: Srikanth Meenakshi; Email: contact@primeinvestor.
Grievance Officer Details: Name: Srikanth Meenakshi; Email: contact@primeinvestor.
